Cargando…

Pharmacokinetics and dose adjustment of etoposide administered in a medium-dose etoposide, cyclophosphamide and total body irradiation regimen before allogeneic hematopoietic stem cell transplantation

BACKGROUND: We investigated the pharmacokinetics of etoposide (ETP) to reduce the inter-individual variations of ETP concentrations in patients with acute leukemia who underwent allogeneic hematopoietic stem cell transplantation. We also carried out an in vivo study using rats to verify the dose adj...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tazawa, Yuki, Shigematsu, Akio, Kasashi, Kumiko, Sugita, Junichi, Endo, Tomoyuki, Kondo, Takeshi, Teshima, Takanori, Iseki, Ken, Sugawara, Mitsuru, Takekuma, Yoh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976473/ https://www.ncbi.nlm.nih.gov/pubmed/27504190 http://dx.doi.org/10.1186/s40780-016-0052-9

Ejemplares similares

Perspectives on the Use of a Medium-Dose Etoposide, Cyclophosphamide, and Total Body Irradiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation: The Japanese Experience from 1993 to Present
por: Imamura, Masahiro, et al.
Publicado: (2019)

Allogeneic hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: potential benefit of medium-dose etoposide conditioning
por: Imamura, Masahiro, et al.
Publicado: (2015)

A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia
por: Shigematsu, Akio, et al.
Publicado: (2015)

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.
por: de Jong, R. S., et al.
Publicado: (1997)

Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review
por: Lewin, Jeremy, et al.
Publicado: (2013)

Conversion of the prodrug etoposide phosphate to etoposide in gastric juice and bile.
por: de Jong, R. S., et al.
Publicado: (1997)

Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
por: Wu, Chunsheng, et al.
Publicado: (2020)

A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.
por: Lowis, S. P., et al.
Publicado: (1998)

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
por: English, M. W., et al.
Publicado: (1996)

Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide
por: Siderov, J, et al.
Publicado: (2002)

Molecular mechanisms of etoposide
por: Montecucco, Alessandra, et al.
Publicado: (2015)

Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2021)

Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients
por: Choi, Jung Yoon, et al.
Publicado: (2020)

High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours.
por: Bisogno, G., et al.
Publicado: (1998)

Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
por: Takami, Akiyoshi
Publicado: (2020)

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
por: Zulian, G. B., et al.
Publicado: (1989)

Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer.
por: Lee, C. R., et al.
Publicado: (1993)

Remarkable response of recurrent endometrial adenocarcinoma to daily oral administration of half-dose etoposide
por: Nakamura, Yasuhiko, et al.
Publicado: (2018)

Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
por: Nagano, Hiroaki, et al.
Publicado: (2016)

High dose of dexamethasone attenuates docetaxel-induced fluid retention in breast cancer treatment
por: Saito, Yoshitaka, et al.
Publicado: (2023)

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022)

Continuous Low-Dose Oral Chemotherapy in Recurrent and Persistent Carcinoma of Cervix Following Chemoradiation: A Comparative Study Between Prolonged Oral Cyclophosphamide and Oral Etoposide
por: Baruah, Upasana, et al.
Publicado: (2014)

Combination Chemotherapy with Cyclophosphamide, Vincristine, Cisplatin and Etoposide(COPE) Combined with Radiotherapy for Small Cell Lung Cancer
por: Nam, Yong Jin, et al.
Publicado: (1995)

Treatment of Primary Mediastinal B-Cell Lymphoma With R-CEOP (Rituximab, Cyclophosphamide, Etoposide, Vincristine, and Prednisone)
por: Cherukuri, Sundar V, et al.
Publicado: (2021)

The effect of etoposide on human CFU-GM.
por: Bailey-Wood, R., et al.
Publicado: (1985)

An Exceptionally Favorable Response to Etoposide and Cisplatin
por: Valecha, Gautam, et al.
Publicado: (2015)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Photochemical Internalization of Etoposide Using Dendrimer Nanospheres Loaded with Etoposide and Protoporphyrin IX on a Glioblastoma Cell Line
por: Lin, Martin Hsiu-Chu, et al.
Publicado: (2021)

Serotonin Syndrome Developing Immediately after the Initiation of Low-Dose Methadone Therapy: A Case Report
por: Kumai, Masayoshi, et al.
Publicado: (2020)

Phase II Study of Cyclophosphamide, Epirubicin, Vincristine, Prednisone, and Etoposide (CEOP-E) for Aggressive Non-Hodgkin's Lymphoma
por: Kim, Jong Gwang, et al.
Publicado: (2004)

Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy
por: Matsukawa, Toshihiro, et al.
Publicado: (2018)

Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
por: Michelagnoli, M P, et al.
Publicado: (1999)

Acute transient parotitis in a child with primitive neuroectodermal tumor after a standard dose etoposide
por: Latha, Magatha Sneha, et al.
Publicado: (2014)

Eco-friendly fluorimetric approaches for the simultaneous estimation of the co-administered ternary mixture: etoposide, moxifloxacin and nalbuphine
por: Tolba, M. M., et al.
Publicado: (2021)

Diffuse Large B-cell Lymphoma Presenting as Bilateral Renal Masses: Successful Treatment with Dose-adjusted REPOCH (Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin) Chemotherapy Regimen
por: Kaur, Anahat, et al.
Publicado: (2019)

Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702
por: Okamoto, H, et al.
Publicado: (2007)

High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels.
por: Kanfer, E. J., et al.
Publicado: (1998)

Successful combination chemotherapy involving clofarabine, cyclophosphamide, and etoposide for pediatric relapsed acute myeloid leukemia: A case report
por: Fujita, Sachio, et al.
Publicado: (2021)

Numerical Analysis of Etoposide Induced DNA Breaks
por: Muslimović, Aida, et al.
Publicado: (2009)

Hypersensitivity to Etoposide in Case of Metastatic Gestational Choriocarcinoma
por: Lazović, Biljana, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t6qcpm6748tq9bd47e9s0kovfr